Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Klein

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Nature Structural & Molecular Biology|February 24, 2009
Cocrystal structure of a class I preQ1 riboswitch reveals a pseudoknot recognizing an essential hypermodified nucleobaseDaniel J Klein, Thomas E Edwards, Adrian R Ferré-D'Amaré
Journal of the American Chemical Society|November 10, 2007
Essential role of an active-site guanine in glmS ribozyme catalysisDaniel J Klein, Michael D Been, Adrian R Ferré-D'Amaré
Plos Neglected Tropical Diseases|September 7, 2018
Typhoid fever in Santiago, Chile: Insights from a mathematical model utilizing venerable archived data from a successful disease control programJillian S Gauld, Hao Hu, Daniel J Klein, et al.
Journal of the American Chemical Society|August 19, 2011
The glmS ribozyme tunes the catalytically critical pK(a) of its coenzyme glucosamine-6-phosphateBo Gong, Daniel J Klein, Adrian R Ferré-D'Amaré, et al.
Journal of Molecular Biology|September 7, 2007
Requirement of helix P2.2 and nucleotide G1 for positioning the cleavage site and cofactor of the glmS ribozymeDaniel J Klein, Sara R Wilkinson, Michael D Been, et al.
Environmental Health Perspectives|March 4, 2011
Most plastic products release estrogenic chemicals: a potential health problem that can be solvedChun Z Yang, Stuart I Yaniger, V Craig Jordan, et al.
Epidemics|July 22, 2025
Improving policy-oriented agent-based modeling with history matching: A case studyDavid O'Gara, Cliff C Kerr, Daniel J Klein, et al.
Pharmacogenetics and Genomics|August 22, 2013
PharmGKB summary: tamoxifen pathway, pharmacokineticsDaniel J Klein, Caroline F Thorn, Zeruesenay Desta, et al.
Infectious Disease Modelling|March 7, 2019
The influence of mobility among high-risk populations on HIV transmission in Western KenyaAnna Bershteyn, Kennedy K Mutai, Adam N Akullian, et al.
Plos One|December 2, 2014
Quantifying the impact of expanded age group campaigns for polio eradicationBradley G Wagner, Matthew R Behrend, Daniel J Klein, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Nature Structural & Molecular Biology|February 24, 2009
Cocrystal structure of a class I preQ1 riboswitch reveals a pseudoknot recognizing an essential hypermodified nucleobaseDaniel J Klein, Thomas E Edwards, Adrian R Ferré-D'Amaré
Journal of the American Chemical Society|November 10, 2007
Essential role of an active-site guanine in glmS ribozyme catalysisDaniel J Klein, Michael D Been, Adrian R Ferré-D'Amaré
Plos Neglected Tropical Diseases|September 7, 2018
Typhoid fever in Santiago, Chile: Insights from a mathematical model utilizing venerable archived data from a successful disease control programJillian S Gauld, Hao Hu, Daniel J Klein, et al.
Journal of the American Chemical Society|August 19, 2011
The glmS ribozyme tunes the catalytically critical pK(a) of its coenzyme glucosamine-6-phosphateBo Gong, Daniel J Klein, Adrian R Ferré-D'Amaré, et al.
Journal of Molecular Biology|September 7, 2007
Requirement of helix P2.2 and nucleotide G1 for positioning the cleavage site and cofactor of the glmS ribozymeDaniel J Klein, Sara R Wilkinson, Michael D Been, et al.
Environmental Health Perspectives|March 4, 2011
Most plastic products release estrogenic chemicals: a potential health problem that can be solvedChun Z Yang, Stuart I Yaniger, V Craig Jordan, et al.
Epidemics|July 22, 2025
Improving policy-oriented agent-based modeling with history matching: A case studyDavid O'Gara, Cliff C Kerr, Daniel J Klein, et al.
Pharmacogenetics and Genomics|August 22, 2013
PharmGKB summary: tamoxifen pathway, pharmacokineticsDaniel J Klein, Caroline F Thorn, Zeruesenay Desta, et al.
Infectious Disease Modelling|March 7, 2019
The influence of mobility among high-risk populations on HIV transmission in Western KenyaAnna Bershteyn, Kennedy K Mutai, Adam N Akullian, et al.
Plos One|December 2, 2014
Quantifying the impact of expanded age group campaigns for polio eradicationBradley G Wagner, Matthew R Behrend, Daniel J Klein, et al.
Pageof 7